APOLIPOPROTEIN A - ANVISA Registration 10287411033
Access comprehensive regulatory information for APOLIPOPROTEIN A in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411033 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10287411033
25351597148201325
30280358000186
Company Information
Dates and Status
Dec 30, 2013
VIGENTE
09/18/2025 19:00:01
APOLIPOPROTEÍNA A
LPA2 (Tina-quant Lipoprotein (a) Gen.2)-cobas c
ROCHE DIAGNOSTICS GMBH
10287411429
Aug 05, 2019
APOLIPOPROTEÍNA A
FAMÍLIA APOLIPOPROTEIN E
WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD
80464810662
Jun 24, 2019
APOLIPOPROTEÍNA A
Preciset Lp(a) Gen.2
ROCHE DIAGNOSTICS GMBH
10287411034
Dec 30, 2013
APOLIPOPROTEÍNA A
ABBOTT CLINICAL CHEMISTRY APOLIPOPROTEIN A1 - APOLIPOPROTEINA A1 ABBOTT BIOQUIMICA
ABBOTT IRELAND DIAGNOSTICS DIVISION
80146501304
Nov 07, 2005